Iotron Medical has been working with the Argonne National Laboratory since 2011 on the scale-up of copper-67 radioisotope production using high-energy electron beam reactions. Copper-67 is a beta emitter with highly desirable properties for theranostic targeted radioisotope therapy (peptides or antibodies). It can also be paired with copper-64 for detailed PET imaging.
Copper-67 is available to order today from Argonne / National Isotope Development Center. Iotron intends to construct a commercial-scale production facility for copper-67 and other photonuclear radioisotopes to supply the market in the near future.
Iotron Medical is part of the Iotron group, an organization pioneering the use of electron beam technology in a wide variety of applications since 1991. Electron beam is used at Iotron’s sites in Vancouver, Canada and Columbia City, Indiana, USA to sterilize medical devices, cross-link polymers used in orthopedics, and sanitize agricultural products. Iotron’s irradiation processes are carried out according to strict regulatory standards including current Good Manufacturing Practice (cGMP).
For more information please visit www.copper67.com or www.iotron.com.